Grifols In Talks For $5B Stake In China's Shanghai RAAS Blood Products
November 23, 2018 at 11:30 AM EST
Grifols would invest in Shanghai RAAS by means of the contribution of its fully owned U.S. subsidiary, Grifols Diagnostic Solutions.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.